Management of Dobutamine Infiltration
Immediately discontinue the dobutamine infusion and administer phentolamine 5-10 mg diluted in 10 mL normal saline via multiple subcutaneous injections into the affected area within 12 hours of extravasation. 1
Immediate Recognition and Initial Steps
Stop the infusion immediately upon recognizing infiltration to prevent further tissue injury, but leave the IV catheter in place initially if phentolamine administration is planned 1
Assess the infiltration site for blanching, coolness, swelling, pain, and other signs of tissue damage 1
Mark the borders of the affected area with a pen to enable objective monitoring of progression or improvement over subsequent hours 1
Antidote Administration: Phentolamine
Phentolamine is the specific antidote for dobutamine extravasation and should be administered as 5-10 mg diluted in 10 mL of normal saline 1
Infiltrate the phentolamine solution into the affected area using multiple subcutaneous injections distributed throughout the zone of extravasation 1
Administer within 12 hours of extravasation for maximum effectiveness; efficacy diminishes significantly after this window 1
The mechanism of phentolamine is alpha-adrenergic blockade, which reverses the vasoconstriction caused by dobutamine's alpha-1 receptor activity 2
Supportive Care Measures
Apply warm compresses to the affected area to promote vasodilation and enhance dispersal of the extravasated drug 1
Elevate the affected extremity above heart level to reduce edema formation and improve venous drainage 1
Monitor the infiltration site every 1-2 hours for the first 24 hours, assessing skin color, temperature, capillary refill, and any progression of tissue injury 1
Surgical Consultation Criteria
Obtain immediate plastic surgery or vascular surgery consultation if:
Compartment syndrome is suspected (progressive pain out of proportion to examination, tense swelling, paresthesias, or diminished pulses) 1
Tissue necrosis develops despite appropriate phentolamine administration and supportive care 1
Large-volume extravasation has occurred (typically >10-20 mL of concentrated dobutamine solution) 1
Prevention Strategies
Use central venous access when prolonged dobutamine infusions are anticipated, particularly for continuous infusions or doses exceeding 5-10 mcg/kg/min 1
Inspect peripheral IV sites frequently during dobutamine administration—at minimum every 1-2 hours—to detect early signs of infiltration 1
Avoid placing peripheral IV catheters in areas with limited subcutaneous tissue or poor venous access (e.g., dorsum of hand in elderly patients) when administering vasoactive agents 1
Clinical Context: Why Dobutamine Causes Tissue Injury
Dobutamine stimulates alpha-1 adrenergic receptors in addition to beta-1 and beta-2 receptors, and this alpha-1 activity causes vasoconstriction when the drug extravasates into tissues 2
The vasoconstrictive effect reduces local blood flow, leading to ischemia and potential tissue necrosis if not reversed promptly 1
This mechanism is similar to other sympathomimetic agents (dopamine, norepinephrine, epinephrine), all of which require phentolamine as the antidote for extravasation 1
Common Pitfalls to Avoid
Do not apply cold compresses or ice, as this will worsen vasoconstriction and tissue ischemia 1
Do not delay phentolamine administration while waiting for surgical consultation; the antidote should be given immediately upon recognition of infiltration 1
Do not remove the IV catheter before phentolamine administration if the catheter is still in place, as it can be used to inject some of the antidote directly into the extravasation site 1
Do not assume small-volume infiltrations are benign; even modest extravasation of concentrated dobutamine can cause significant tissue injury due to its alpha-adrenergic effects 1